Log in
Enquire now
‌

US Patent 9969811 Pertuzumab variants and evaluation thereof

Patent 9969811 was granted and assigned to Genentech on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Genentech
Genentech
Current Assignee
Genentech
Genentech
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9969811
Date of Patent
May 15, 2018
Patent Application Number
15788574
Date Filed
October 19, 2017
Patent Citations Received
‌
US Patent 11655305 Treatment of metastatic breast cancer
0
‌
US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer
0
‌
US Patent 12110341 Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
0
‌
US Patent 11654105 Subcutaneous HER2 antibody formulations
0
‌
US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer
0
Patent Primary Examiner
‌
Laura B Goddard
Patent abstract

The present application discloses variants of Pertuzumab. In particular, it discloses: an unpaired cysteine variant comprising Cys23/Cys88 unpaired cysteines in one or both variable light domains of Pertuzumab, an afucosylated variant of Pertuzumab, a low-molecular-weight-species (LMWS) of Pertuzumab, and a high-molecular-weight-species (HMWS) or Pertuzumab. The application further discloses the isolated variants, compositions, pharmaceutical compositions, and articles of manufacture comprising the variants, as well as methods of making and characterizing the variants and compositions thereof.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9969811 Pertuzumab variants and evaluation thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.